S100A4 and Alzheimer disease: We evaluated the effects of AD-MSCs treatment on the expression levels of transforming growth factor beta (TGF-β), fibroblast-specific protein-1 (FSP-1) and smooth muscle actin (α-SMA) on cells derived from PD-effluent.